Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis.

Gentile A, Rossi S, Studer V, Motta C, De Chiara V, Musella A, Sepman H, Fresegna D, Musumeci G, Grasselli G, Haji N, Weiss S, Hayardeny L, Mandolesi G, Centonze D.

J Neuroimmune Pharmacol. 2013 Jun;8(3):651-63. doi: 10.1007/s11481-013-9436-x. Epub 2013 Jan 31.

PMID:
23370991
2.

Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis.

Musumeci G, Grasselli G, Rossi S, De Chiara V, Musella A, Motta C, Studer V, Bernardi G, Haji N, Sepman H, Fresegna D, Maccarrone M, Mandolesi G, Centonze D.

Neurobiol Dis. 2011 Sep;43(3):669-77. doi: 10.1016/j.nbd.2011.05.018. Epub 2011 Jun 6.

PMID:
21672630
3.

Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis.

Ruffini F, Rossi S, Bergamaschi A, Brambilla E, Finardi A, Motta C, Studer V, Barbieri F, De Chiara V, Hayardeny L, Comi G, Centonze D, Martino G.

Mult Scler. 2013 Jul;19(8):1084-94. doi: 10.1177/1352458512469698. Epub 2012 Dec 11.

PMID:
23232603
4.

Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.

Aharoni R, Vainshtein A, Stock A, Eilam R, From R, Shinder V, Arnon R.

J Autoimmun. 2011 Nov;37(3):228-41. doi: 10.1016/j.jaut.2011.06.003. Epub 2011 Jul 14.

PMID:
21752599
5.

Restoration of axon conduction and motor deficits by therapeutic treatment with glatiramer acetate.

Moore S, Khalaj AJ, Patel R, Yoon J, Ichwan D, Hayardeny L, Tiwari-Woodruff SK.

J Neurosci Res. 2014 Dec;92(12):1621-36. doi: 10.1002/jnr.23440. Epub 2014 Jul 3.

6.

Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?

Jee Y, Liu R, Bai XF, Campagnolo DI, Shi FD, Vollmer TL.

Int Immunol. 2006 Apr;18(4):537-44. Epub 2006 Feb 15.

PMID:
16481342
7.

Immunomodulation neuroprotection and remyelination - the fundamental therapeutic effects of glatiramer acetate: a critical review.

Aharoni R.

J Autoimmun. 2014 Nov;54:81-92. doi: 10.1016/j.jaut.2014.05.005. Epub 2014 Jun 14. Review.

PMID:
24934599
8.

Magnetic resonance imaging characterization of different experimental autoimmune encephalomyelitis models and the therapeutic effect of glatiramer acetate.

Aharoni R, Sasson E, Blumenfeld-Katzir T, Eilam R, Sela M, Assaf Y, Arnon R.

Exp Neurol. 2013 Feb;240:130-44. doi: 10.1016/j.expneurol.2012.11.004. Epub 2012 Nov 12.

PMID:
23153580
9.

miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation.

Mandolesi G, De Vito F, Musella A, Gentile A, Bullitta S, Fresegna D, Sepman H, Di Sanza C, Haji N, Mori F, Buttari F, Perlas E, Ciotti MT, Hornstein E, Bozzoni I, Presutti C, Centonze D.

J Neurosci. 2017 Jan 18;37(3):546-561. doi: 10.1523/JNEUROSCI.0851-16.2016.

10.

Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis.

Musella A, Mandolesi G, Gentile A, Rossi S, Studer V, Motta C, Sepman H, Fresegna D, Haji N, Paolillo A, Matarese G, Centonze D.

J Neuroimmunol. 2013 Nov 15;264(1-2):8-13. doi: 10.1016/j.jneuroim.2013.08.009. Epub 2013 Aug 31.

PMID:
24045165
11.
12.

B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis.

Kala M, Rhodes SN, Piao WH, Shi FD, Campagnolo DI, Vollmer TL.

Exp Neurol. 2010 Jan;221(1):136-45. doi: 10.1016/j.expneurol.2009.10.015. Epub 2009 Oct 29.

PMID:
19879259
13.

The mechanism of action of glatiramer acetate in multiple sclerosis and beyond.

Aharoni R.

Autoimmun Rev. 2013 Mar;12(5):543-53. doi: 10.1016/j.autrev.2012.09.005. Epub 2012 Oct 7. Review.

PMID:
23051633
14.

Neuroprotection and neurogeneration in MS and its animal model EAE effected by glatiramer acetate.

Arnon R, Aharoni R.

J Neural Transm (Vienna). 2009 Nov;116(11):1443-9. doi: 10.1007/s00702-009-0272-3. Epub 2009 Aug 11. Review.

PMID:
19669693
15.

CD4(+)CD25(+) regulatory T cells contribute to the therapeutic effects of glatiramer acetate in experimental autoimmune encephalomyelitis.

Jee Y, Piao WH, Liu R, Bai XF, Rhodes S, Rodebaugh R, Campagnolo DI, Shi FD, Vollmer TL.

Clin Immunol. 2007 Oct;125(1):34-42. Epub 2007 Jul 16.

PMID:
17632037
16.

Increased expression of B cell-associated regulatory cytokines by glatiramer acetate in mice with experimental autoimmune encephalomyelitis.

Begum-Haque S, Sharma A, Christy M, Lentini T, Ochoa-Reparaz J, Fayed IF, Mielcarz D, Haque A, Kasper LH.

J Neuroimmunol. 2010 Feb 26;219(1-2):47-53. doi: 10.1016/j.jneuroim.2009.11.016. Epub 2010 Jan 19.

PMID:
20034680
17.

TNF-α-mediated anxiety in a mouse model of multiple sclerosis.

Haji N, Mandolesi G, Gentile A, Sacchetti L, Fresegna D, Rossi S, Musella A, Sepman H, Motta C, Studer V, De Chiara V, Bernardi G, Strata P, Centonze D.

Exp Neurol. 2012 Oct;237(2):296-303. doi: 10.1016/j.expneurol.2012.07.010. Epub 2012 Jul 24.

PMID:
22836148
18.

Neuroprotective effect of combination therapy of glatiramer acetate and epigallocatechin-3-gallate in neuroinflammation.

Herges K, Millward JM, Hentschel N, Infante-Duarte C, Aktas O, Zipp F.

PLoS One. 2011;6(10):e25456. doi: 10.1371/journal.pone.0025456. Epub 2011 Oct 13.

19.

Glatiramer acetate guards against rapid memory decline during relapsing-remitting experimental autoimmune encephalomyelitis.

LoPresti P.

Neurochem Res. 2015 Mar;40(3):473-9. doi: 10.1007/s11064-014-1491-z. Epub 2014 Dec 7.

PMID:
25481047
20.

Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.

Hu X, Qin X.

Int J Mol Med. 2013 May;31(5):1209-21. doi: 10.3892/ijmm.2013.1306. Epub 2013 Mar 15.

PMID:
23525227

Supplemental Content

Support Center